Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 15(5): e0233086, 2020.
Article in English | MEDLINE | ID: mdl-32407350

ABSTRACT

BACKGROUND: Implant associated infections such as periprosthetic joint infections are difficult to treat as the bacteria form a biofilm on the prosthetic material. This biofilm complicates surgical and antibiotic treatment. With rising antibiotic resistance, alternative treatment options are needed to treat these infections in the future. The aim of this article is to provide proof-of-principle data required for further development of radioimmunotherapy for non-invasive treatment of implant associated infections. METHODS: Planktonic cells and biofilms of Methicillin-resistant staphylococcus aureus are grown and treated with radioimmunotherapy. The monoclonal antibodies used, target wall teichoic acids that are cell and biofilm specific. Three different radionuclides in different doses were used. Viability and metabolic activity of the bacterial cells and biofilms were measured by CFU dilution and XTT reduction. RESULTS: Alpha-RIT with Bismuth-213 showed significant and dose dependent killing in both planktonic MRSA and biofilm. When planktonic bacteria were treated with 370 kBq of 213Bi-RIT 99% of the bacteria were killed. Complete killing of the bacteria in the biofilm was seen at 185 kBq. Beta-RIT with Lutetium-177 and Actinium-225 showed little to no significant killing. CONCLUSION: Our results demonstrate the ability of specific antibodies loaded with an alpha-emitter Bismuth-213 to selectively kill staphylococcus aureus cells in vitro in both planktonic and biofilm state. RIT could therefore be a potentially alternative treatment modality against planktonic and biofilm-related microbial infections.


Subject(s)
Methicillin-Resistant Staphylococcus aureus , Prosthesis-Related Infections/radiotherapy , Radioimmunotherapy , Staphylococcal Infections/radiotherapy , Actinium/therapeutic use , Antibodies, Monoclonal/therapeutic use , Biofilms/growth & development , Biofilms/radiation effects , Bismuth/therapeutic use , Humans , In Vitro Techniques , Lutetium/therapeutic use , Methicillin-Resistant Staphylococcus aureus/immunology , Methicillin-Resistant Staphylococcus aureus/radiation effects , Plankton/growth & development , Plankton/radiation effects , Proof of Concept Study , Radioisotopes/therapeutic use , Teichoic Acids/immunology
2.
Appl Radiat Isot ; 137: 190-193, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29655123

ABSTRACT

This pilot study represents a paradigm shift, using BNCT for the treatment of bacterial overgrowth on surgically implanted medical devices. In this study, titanium diboride disks were inoculated with S. aureus and irradiated in a thermal neutron beam. After a delivery of 2.6 × 1012 n/cm2 the surviving fraction of S. aureus on an irradiated disk was 3.1 × 10-5 when compared with non-irradiated controls. This pilot study demonstrates proof of principle of boron neutron capture therapy for infection control (BNCIC).


Subject(s)
Boron Neutron Capture Therapy/methods , Prosthesis-Related Infections/radiotherapy , Staphylococcal Infections/radiotherapy , Staphylococcus aureus/radiation effects , Boron Compounds , Computer Simulation , Humans , In Vitro Techniques , Infection Control/methods , Pilot Projects , Prosthesis-Related Infections/prevention & control , Radiotherapy Dosage , Staphylococcal Infections/prevention & control , Titanium
3.
J Biomater Appl ; 18(4): 237-45, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15070512

ABSTRACT

Infection of implanted medical devices by Gram-positive organisms such as Staphylococcus ssp. is a serious concern in the biomaterial community. In this research the application of low frequency ultrasound to enhance the activity of vancomycin against implanted Staphylococcus epidermidis biofilms was examined. Polyethylene disks covered with a biofilm of S. epidermidis were implanted subcutaneously in rabbits on both sides of their spine. The rabbits received systemic vancomycin for the duration of the experiment. Following 24 h of recovery, one disk was insonated for 24 or 48 h while the other was a control. Disks were removed and viable bacteria counted. At 24 h of insonation, there was no difference in viable counts between control and insonated biofilms, while at 48 h of insonation there were statistically fewer viable bacteria in the insonated biofilm. The S. epidermidis biofilms responded favorably to combinations of ultrasound and vancomycin, but longer treatment times are required for this Gram-positive organism than was observed previously for a Gram-negative species.


Subject(s)
Biofilms/drug effects , Biofilms/radiation effects , Cell Survival/drug effects , Cell Survival/radiation effects , Staphylococcus epidermidis/drug effects , Staphylococcus epidermidis/radiation effects , Vancomycin/administration & dosage , Animals , Anti-Bacterial Agents/administration & dosage , Combined Modality Therapy , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Female , Prosthesis-Related Infections/drug therapy , Prosthesis-Related Infections/radiotherapy , Rabbits , Staphylococcal Infections/drug therapy , Staphylococcal Infections/radiotherapy , Ultrasonic Therapy/methods , Ultrasonics
4.
J Arthroplasty ; 16(8): 1075-7, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11740767

ABSTRACT

We report a patient who underwent revision hip arthroplasty with preoperative radiation after a septic loosening of the primary hip prosthesis. Subsequently the patient presented with a dislocation of the hip. During the closed reduction with general anesthesia, a rupture of the arteria profunda femoris occurred. The patient was treated by angiographic obliteration of the arteria profunda femoris followed by an open reduction and augmentation of the acetabular component.


Subject(s)
Arteries/injuries , Arthroplasty, Replacement, Hip , Hip Dislocation/therapy , Manipulation, Orthopedic/adverse effects , Prosthesis-Related Infections/radiotherapy , Aged , Female , Hip Dislocation/etiology , Humans , Prosthesis Failure , Prosthesis-Related Infections/drug therapy , Reoperation , Risk Factors , Rupture
5.
Lasers Surg Med ; 29(5): 448-54, 2001.
Article in English | MEDLINE | ID: mdl-11891733

ABSTRACT

BACKGROUND AND OBJECTIVE: Bacteria that cause infection of vascular prosthetic grafts produce an exopolysaccharide matrix known as biofilm. Growth in biofilms protects the bacteria from leukocytes, antibodies and antimicrobial drugs. Laser-generated shock waves (SW) can disrupt biofilms and increase drug penetration. This study investigates the possibility of increasing antibiotic delivery and sterilization of vascular prosthetic graft. STUDY DESIGN/MATERIALS AND METHODS: Strains of Staphylococcus epidermidis and S. aureus were isolated from infected prosthetic grafts obtained directly from patients. Dacron grafts were inoculated with the isolated bacteria, which were allowed to form adherent bacterial colonies. The colonized grafts underwent the following treatments: (a) antibiotic (vancomycin) alone; (b) antibiotic and SW (c) saline only; and (d) saline and SW. Six hours after treatment, the grafts were sonicated, the effluent was cultured and the colony forming units (CFU) were counted. RESULTS: CFU recovered from control grafts colonized by S. epidermidis were comparable: saline, 3.05 x 10(8) and saline+SW 3.31 x 10(8). The number of S. epidermidis CFU diminished to 7.61 x 10(6) after antibiotic treatment but the combined antibiotic+SW treatment synergistically decreased CFU number to 1.27 x 10(4) (P<0.001). S. aureus showed a higher susceptibility to the antibiotic: 2.26 x 10(6) CFU; antibiotic +SW treatment also had an incremental effect: 8.27 x 10(4) CFU (P<0.001). CONCLUSIONS: This study demonstrates that laser-generated shock waves have no effects alone, but can enhance the effectiveness of antibiotics against bacteria associated with prosthetic vascular graft biofilms, suggesting that this treatment may be of value as adjunctive therapy for prosthetic graft infections.


Subject(s)
Blood Vessel Prosthesis/adverse effects , Lasers , Prosthesis-Related Infections/prevention & control , Prosthesis-Related Infections/radiotherapy , Staphylococcal Infections/prevention & control , Staphylococcal Infections/radiotherapy , Sterilization/methods , Anti-Bacterial Agents/therapeutic use , Combined Modality Therapy , Humans , Prosthesis-Related Infections/drug therapy , Staphylococcal Infections/drug therapy , Staphylococcus aureus/isolation & purification , Staphylococcus epidermidis/isolation & purification , Sterilization/instrumentation , Surgical Wound Infection/prevention & control , Surgical Wound Infection/radiotherapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...